Skip to main content
SpringerLink
Log in

Reduction of heart rate — Really a new concept in treating angina pectoris?

  • Conference paper
Sinus node inhibitors

Summary

Myocardial ischemia causing chest pain in patients with angina pectoris is due to an imbalance between coronary blood flow and myocardial metabolic demand. Heart rate is a major determinant of oxygen consumption and metabolic demand, and drugs known to reduce heart rate, such as β-blockers and some calcium blockers have well established effects in patients with angina pectoris. In addition to its importance as a determinant of oxygen consumption, heart rate is also an independent predictor, both of risk of developing acute myocardial infarction as well as a predictor for later complications including death. Increased heart rate can be due to either increased sympathetic activity and/or reduced parasympathetic activity. Psychosocial stress, an important risk factor for development of coronary artery disease, is characterized by an increase in heart rate and systolic blood pressure. β-blockers and calcium blockers are well established in the therapy of ischemic heart disease, and β-blockers are also known to reduce and prevent infarct development and mortality after myocardial infarction. It seems reasonable to believe that new drugs with specific effects on heart rate, without any influence on contractility, could be useful in the therapy of patients with ischemic heart disease, with symptoms of angina pectoris, as well as with supraventricular tachycardia and congestive heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barry WH, Brooker JZ, Alderman EL, Harrison DC (1974) Changes in diastolic stiffness and tone of the left ventricle during angina pectoris. Circulation 49: 255–263

    PubMed  CAS  Google Scholar 

  2. Beta-blocker Heart Attack Trial Research Group (1982) A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 247: 1707–1714

    Article  Google Scholar 

  3. Chierchia S, Genosa S, Grazier J J (1987) Beta-blockers for the treatment of angina pectoris, indications in relation to pathophysiological mechanisms. J Cardiovasc Pharmacol 10: 529–533

    Google Scholar 

  4. Collin P, Fox KM (1990) Pathophysiology of angina. Lancet i: 94–96

    Article  Google Scholar 

  5. Coronary Drug Project Research Group (1974) Factors influencing long-term prognosis after recovery from myocardial infarction—three-year findings of the Coronary Drug project. J Chron Dist 27: 267–285

    Article  Google Scholar 

  6. Davies PF, Olesen S-P, Clapham DE, Morrel EM, Schoen FJ (1988) Endothelial communication. State of the art lecture. Hypertension 11 (6) part 2: 563–572

    Google Scholar 

  7. Frishman WH (1986) Beta adrenergic blockade for the treatment of angina pectoris. In: Weiner D, Frishman WD (eds): Therapy of angina pectoris. New York, Marcel Dekker Inc

    Google Scholar 

  8. Gilpin E, Olshen R, Henning H, Ross J Jr (1983) Risk prediction after myocardial infarction, comparison of three multivariate methodologies. Cardiology 70: 73–84

    Article  PubMed  CAS  Google Scholar 

  9. Gundersen T, Gottum P, Pedersen T, Kjekshus KJ for the Norwegian Multicenter Study Group (1986) Effect of timolol on mortality and reinfarction after acute myocardial infarction: Prognostic importance of heart rate at rest. Am J Cardiol 58: 20–25

    Article  PubMed  CAS  Google Scholar 

  10. Held PH, Yusuf S, Furberg DC (1989) Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ 299: 1187–1192

    Article  PubMed  CAS  Google Scholar 

  11. Herlitz J, Hjalmarson A (1986) The role of beta-blockade in the limitation of infarct development. Br Heart J 7: 916–924

    CAS  Google Scholar 

  12. Hjalmarson Å (1991) Cardioprotection after myocardial infarction. Clin Cardiol. Accepted for publication

    Google Scholar 

  13. Hjalmarson Å for the MIAMI Trial Research Project (1985) MIAMI: Metoprolol in Acute Myocardial Infarction. Am J Cardiol 56: 1G–57G

    Article  Google Scholar 

  14. Hjalmarson Å, Gilpin EA, Kjekshus J, Schieman G, Nicod P, Henning H, Ross J Jr (1990) Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 65: 547–553

    Article  PubMed  CAS  Google Scholar 

  15. Hjalmarson A, Herlitz J (1984) The Goteborg Metoprolol Trial in acute myocardial infarction. Am J Cardiol 53: 1D–50D

    Google Scholar 

  16. Indolfi C, Guth BD, Miura T, Miyazaki S, Schulz R, Ross J Jr (1989) Mechanisms of improved ischemic regional dysfunction by bradycardia. Studies on UL-FS49 in swine. Circulation 80: 983–993

    Article  PubMed  CAS  Google Scholar 

  17. Kjekshus J (1987) Heart rate reduction—a mechanism of benefit? Eur Heart J 8 (suppl L): 115–122

    PubMed  Google Scholar 

  18. Madsen EB, Gilpin E, Henning H, Ahnve S, LeWinter M, Ceretto W, Joswig W, Collins D, Pitt W, Ross J Jr (1984) Prediction of late mortality after myocardial infarction from variables measures at different times during hospitalization. Am J Cardiol 53: 47–54

    Article  PubMed  CAS  Google Scholar 

  19. Maseri A, Chierchia S, Kaski JC (1985) Mixed angina pectoris. Am J Cardiol 56: 30E–33E

    Article  PubMed  CAS  Google Scholar 

  20. Morris Jr JJ (1990) Mechanisms of ischemia in coronary artery disease: Spontaneou decrease in coronary blood supply. Am Heart J 120: 746–756

    Article  PubMed  Google Scholar 

  21. Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP (1988) Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 77 (1): 43–52

    Article  PubMed  CAS  Google Scholar 

  22. Norwegian Multicenter Study Group (1981) Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304: 801–807

    Article  Google Scholar 

  23. Packer M (1989) Drug therapy. Combined beta-adrenergic and calcium-entry blockade in angina pectoris. N Eng 1 J Med 320: 709–718

    CAS  Google Scholar 

  24. The Beta Blockeer Pooling Project (BBPP) (1988) Subgroup findings from randomized trials in postinfarction patients. Eur Heart J 9: 8–16

    Google Scholar 

  25. The Danish Study Group on Verapamil in Myocardial Infarction (1990) Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II—DAVIT II). Am J Cardiol 66: 779–785

    Article  Google Scholar 

  26. Tibblin G, Eriksson C-G, Bjuro T, Georgescu D, Svardsudd C (1975) Heart rate and heart rate variability a risk factor for the development of ischaemic heart disease (IHD) in the “men born in 1913 study”—a ten years follow-up. IRGS Medical Science: Cardiovascular System: Social and Occupational Medicine 3: 95. (abstr)

    Google Scholar 

  27. Vane JR, Anggard EE, Botting RM (1990) Regulatory functions of the vascular endothelium. N Engl J Med 323 (1): 27–36

    Article  PubMed  CAS  Google Scholar 

  28. Waagstein F, Hjalmarson A (1875) Double-blind study of the effect of cardioselective beta-blockade on chest pain in acute myocardial infarction. Acta Med Scand 587: 201–208

    Google Scholar 

  29. Wikstrand J, Warnold I, Olsson G, Tuomilehto J, Elmfeldt D, Berglund G; on behalf of the Advisory Committee (1988) Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY Study. JAMA 259 (13) 1976–1982

    Article  PubMed  CAS  Google Scholar 

  30. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM (1989) Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications. Circulation 80: 198–205

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Medicine I, and Wallenberg Laboratory, University of Göteborg, Sahlgren’s Hospital, S-41345, Göteborg, Sweden

    Åke Hjalmarson MD

Authors
  1. Åke Hjalmarson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Wallenberg Laboratory for Cardiovascular Research Sahlgren’s Hospital, Gothenburg University, S-41345, Gothenburg, Sweden

    Å. Hjalmarson (Professor of Cardiology) (Professor of Cardiology)

  2. Cardiovascular Research Foundation, STICARES, Valkeniersweg 79, NL-3075 AZ, Rotterdam, The Netherlands

    W. J. Remme

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Hjalmarson, Å. (1991). Reduction of heart rate — Really a new concept in treating angina pectoris?. In: Hjalmarson, Å., Remme, W.J. (eds) Sinus node inhibitors. Steinkopff. https://doi.org/10.1007/978-3-642-72458-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72458-9_1

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-0861-3

  • Online ISBN: 978-3-642-72458-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation